IFWM
BMY.RT

Institute for Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Institute for Wealth Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-811,275
Closed -$560K – 488
2020
Q4 		$560K Buy
811,275
+162,812
+25% +$347K 0.11% 226
2020
Q3 		$1.46M Buy
648,463
+111,548
+21% +$319K 0.33% 77
2020
Q2 		$1.92M Buy
536,915
+329,054
+158% +$1.19M 0.47% 41
2020
Q1 		$790K Sell
207,861
-1,580
-0.8% -$5.21K 0.24% 112
2019
Q4 		$630K Buy
+209,441
New +$545K 0.14% 213

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Institute for Wealth Management's BMY.RT Position: Q1 2021 in Review

Institute for Wealth Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 811,275 shares — an estimated $560K sold.

Institute for Wealth Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1.92M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Institute for Wealth Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Institute for Wealth Management sold 811,275 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $560K.
  • Institute for Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Institute for Wealth Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.92M in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Institute for Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.